ALI HEALTH Announces Leadership Transition: Yu Yong Appointed New Board Chairman
Stock News
Sep 11
ALI HEALTH (00241) has officially announced a significant leadership change, effective from the close of business on September 11, 2026.
Mr. Yu Yong has been appointed as Executive Director, Board Chairman, Chief Executive Officer, Chairman of the Nomination Committee, and the company's Authorized Representative under Rule 3.05 of the Hong Kong Stock Exchange's Securities Listing Rules.
Concurrently, Mr. Shen Difan has stepped down from his roles as Chairman, CEO, Chairman of the Nomination Committee, and Authorized Representative, bringing a formal conclusion to his tenure in these leadership positions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.